Soc. Generale Discount Zert FRE 3.../ DE000SV7Q5M1 /
16/12/2024 8:18:51 | Diferencia- | Bid22:00:38 | Ask22:00:38 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
21.98EUR | - | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
FRESENIUS SE+CO.KGAA... | - - | 31/12/2024 | Call |
GlobeNewswire
24/04
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23/04
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23/02
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página